Compound Summary


Glucomannan Hydrolysate
  Experimental Data
 Glucomannan Hydrolysate

Species Dose Unit Control(Avg days) Treatment(Avg days) Avg/Med Lifespan Change(%) Control(Max days) Treatment(Max days) Max Lifespan Change(%) Significant Strain Gender PubMed Avg/Med Lifespan Change tab
Drosophila melanogaster 0.250000000000000 % 11.700000000000000 S Oregon-R FEMALES 30252027 Active
Drosophila melanogaster 0.250000000000000 % 17.660000000000000 S Canton-S FEMALES 30252027 Active
Drosophila melanogaster 0.250000000000000 % 10.100000000000000 S DGPR FEMALES 30252027 Active
Drosophila melanogaster 0.250000000000000 % 17.660000000000000 S DGPR FEMALES 30252027 Active
Drosophila melanogaster 0.250000000000000 % 13.400000000000000 S DGPR FEMALES 30252027 Active
Drosophila melanogaster 0.250000000000000 % 20.200000000000000 S B18 MALES 30252027 Active
Drosophila melanogaster 0.250000000000000 % 7.300000000000000 S DGPR FEMALES 30252027 Active
Drosophila melanogaster 0.250000000000000 % 14.880000000000000 S B18 FEMALES 30252027 Active
Drosophila melanogaster 0.250000000000000 % 27.480000000000000 S B18 FEMALES 30252027 Active
  Experimental Data Visualization
 Glucomannan Hydrolysate

  Statistics Data
 Glucomannan Hydrolysate

Species Avg/Med Lifespan Change(%) Max Lifespan Change(%) Count Reference Count Data point
Drosophila melanogaster 27.480000000000000 1 9
  Statistics Data Visualization
 Glucomannan Hydrolysate